Free Trial
NASDAQ:SLRN

Acelyrin (SLRN) Stock Price, News & Analysis

Acelyrin logo
$2.27 0.00 (0.00%)
As of 05/21/2025

About Acelyrin Stock (NASDAQ:SLRN)

Key Stats

Today's Range
$2.27
$2.27
50-Day Range
$2.05
$2.58
52-Week Range
$1.85
$7.25
Volume
N/A
Average Volume
1.29 million shs
Market Capitalization
$229.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.60
Consensus Rating
Hold

Company Overview

Receive SLRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acelyrin and its competitors with MarketBeat's FREE daily newsletter.

SLRN Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Alumis and ACELYRIN Announce Amended Merger Agreement
See More Headlines

SLRN Stock Analysis - Frequently Asked Questions

Acelyrin's stock was trading at $3.14 at the start of the year. Since then, SLRN shares have decreased by 27.7% and is now trading at $2.27.

Acelyrin, Inc. (NASDAQ:SLRN) announced its quarterly earnings results on Wednesday, May, 14th. The company reported ($0.55) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.95) by $0.40.

Acelyrin (SLRN) raised $540 million in an initial public offering (IPO) on Friday, May 5th 2023. The company issued 30,000,000 shares at $18.00 per share.

Shares of SLRN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Acelyrin investors own include Tesla (TSLA), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), JPMorgan Chase & Co. (JPM), Walmart (WMT) and Netflix (NFLX).

Company Calendar

Last Earnings
5/14/2025
Today
7/06/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SLRN
Fax
N/A
Employees
135
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$9.60
High Stock Price Target
$20.00
Low Stock Price Target
$3.00
Potential Upside/Downside
+322.9%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$381.64 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$6.74 per share
Price / Book
0.34

Miscellaneous

Free Float
86,682,000
Market Cap
$229.17 million
Optionable
Optionable
Beta
1.07
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:SLRN) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners